Apellis Pharmaceuticals Other Current Borrowings (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

21.01 +0.54 (+2.64%) USD | NASDAQ | Jan 21, 10:43

View Other Current Borrowings (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Borrowings (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Borrowings (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Borrowings (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Ionis Pharmaceuticals, Inc.	Upgrade
Fortress Biotech, Inc.	Upgrade
Sarepta Therapeutics, Inc.	--